1. Karmarkar, A.B., 2017. A review of drug discovery, development and clinical research. Int. J. Res. Trends Innovation, 2: 202-213.
2. Karmarkar, A.B. and A.D. Chachad, 2017. Regulatory changes: Overcoming hurdles. Ingredients South Asia, 10: 57-60.
3. Karmarkar, A.B. and A. Drugs, 2017. Focus on drug discovery, development, clinical research, and pharmacoeconomics. Int. J. Sci. Eng. Dev. Res., 2: 461-474.
4. Karmarkar, AB., 2016. Determination of relationship and frequency of sensorineural hearing loss in previously diagnosed diabetes mellitus and/or hypertensive adults using qualitative semi-structured interviews. South Am. J. Clin. Res., .
   Direct Link  |  
5. Karmarkar, A.B., A.D. Deodhar and A.A. Holikar, 2014. Indian chemical industry: A potential chemical hub for exploration at world market. Pharma Util., Vol. 8. .
   Direct Link  |  
6. Karmarkar, A.B. and P.S. Mahadik, 2014. Commodity chemicals: On rapid growth path. Ingredients South Asia, 2014: 44-46.
7. Bhide, P.H. and A.B. Karmarkar, 2014. Need of polymers for solubility enhancement. Express Pharma, 9: 58-59.
   Direct Link  |  
8. Karmarkar, A.B., 2013. Speciality chemicals: An emerging sector. Ingredients South Asia, 6: 70-72.
   Direct Link  |  
9. Karmarkar, A.B., 2013. Oxygen scavengers: Key for protecting integrity. Ingredients South Asia, 6: 72-73.
   Direct Link  |  
10. Karmarkar, A.B., 2013. Impact of recent economic changes on R and D. Ingredients South Asia, 6: 40-44.
11. Karmarkar, A.B., 2013. Facility design requirements for high potency APIs. Exp. Pharm., 8: 46-47.
12. Karmarkar, A.B., 2013. Destinations for clinical trials in continent. Ingredients South Asia, 6: 42-44.
13. Karmarkar, A.B., 2013. Clinical trials in southeast Asia: A viewpoint. Ingredients South Asia, 6: 35-39.
    Direct Link  |  
14. Karmarkar, A.B., 2013. Clinical trials in Middle East and North Africa (MENA). Ingredients South Asia, 6: 36-38.
15. Karmarkar, A.B. and P. Mahadik, 2013. Regulatory changes in clinical trials: Update of year 2013. Ingredients South Asia, 2013: 71-73.
16. Hosmani, A.H., Y.S. Thorat, I.D. Gonjari and A.B. Karmarkar, 2013. Formation and characterisation of carbopol 971P-PVP interpolymer complex and its application in sustained delivery of acyclovir. J. Adv. Pharm. Educ. Res., 3: 94-101.
    Direct Link  |  
17. Khan, R., P.K. Sahu, A. Pal and A.B. Karmarkar, 2012. Convenient method to induce orofacial dyskinesia: A novel animal model of tardive dyskinesia. Pharm. Utility, Vol. 6. .
    Direct Link  |  
18. Karmarkar, A.B., 2012. Use of carriers in liquisolid technology. Ingredients South Asia, 6: 59-60.
19. Karmarkar, A.B., 2012. Trends in dissolution enhancement technologies. Ingredients South Asia, 5: 38-40.
    Direct Link  |  
20. Karmarkar, A.B., 2012. Reporting adverse drug reactions: A view on ADR dictionaries. Pharm. Utility, 6: 1-4.
    Direct Link  |  
21. Karmarkar, A.B., 2012. Regulations in India, US, Europe and beyond. Ingredients South Asia, 6: 84-88.
    Direct Link  |  
22. Karmarkar, A.B., 2012. Penetration enhancers are key ingredients. Ingredients South Asia, 5: 20-22.
    Direct Link  |  
23. Karmarkar, A.B., 2012. Novel in situ gelling is gaining ground. Ingredients South Asia, 5: 20-22.
    Direct Link  |  
24. Karmarkar, A.B., 2012. Novel excipients: The way ahead for drug development. Chronicle Pharmabiz, Vol. 12. .
    Direct Link  |  
25. Karmarkar, A.B., 2012. High potency is fastest growing segment. Ingredients South Asia, 5: 50-52.
    Direct Link  |  
26. Karmarkar, A.B., 2012. Clinical trials in South America: The laws. Ingredients South Asia, 5: 40-42.
    Direct Link  |  
27. Karmarkar, A.B., 2012. An overview of GLP compliance in India. Chronicle Pharmabiz, 12: 19-20.
    Direct Link  |  
28. Karmarkar, A.B., 2011. Current trends in clinical research: Indian perspective. WebmedCentral J. Clin. Res. Healthcare Manage., Vol. 2. 10.9754/journal.wmc.2012.002996.
    CrossRef  |  Direct Link  |  
29. Karmarkar, A.B., I.D. Gonjari, A.H. Hosmani and P.N. Dhabale, 2010. Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. Drug Discoveries Ther., 4: 26-32.
    PubMed  |  Direct Link  |  
30. Karmarkar, A.B., I.D. Gonjari and A.H. Hosmani, 2010. Liquisolid technology for Dissolution rate enhancement or sustained release. Expert Opinion Drug Delivery, 7: 1227-1234.
    CrossRef  |  PubMed  |  Direct Link  |  
31. Karmarkar, A.B., 2010. Effect of Ceolus KG-802 on dissolution rate of fenofibrate liquisolid tablets: Preformulation and Formulation development studies. Drug Discoveries Ther., 4: 493-498.
    PubMed  |  Direct Link  |  
32. Gonjari, I.D., A.B. Karmarkar, A.H. Hosmani, T.S. Khade and R.B. Navale, 2010. Use of factorial design in formulation and evaluation of ophthalmic gels of gatifloxacin: Comparison of different mucoadhesive polymers. Drug Discoveries Ther., 4: 423-434.
    PubMed  |  Direct Link  |  
33. Karmarkar, A.B., I.D. Gonjari, A.H. Hosmani, P.N. Dhabale and S.B. Bhise, 2009. Use of melt solidification technique for preparation of Fenofibrate beads: A technical note. Digest J. Nanomaterials Biostructures, 4: 291-297.
    Direct Link  |  
34. Karmarkar, A.B., I.D. Gonjari, A.H. Hosmani, P.N. Dhabale and S.B. Bhise, 2009. Liquisolid tablets: A novel approach for drug delivery. Int. J. Health Res., 2: 45-50.
    CrossRef  |  Direct Link  |  
35. Karmarkar, A.B., I.D. Gonjari, A.H. Hosmani, P.N. Dhabale and S.B. Bhise, 2009. Dissolution rate enhancement of Fenofibrate using liquisolid tablet technique. Latin Am. J. Pharm., 28: 219-225.
    Direct Link  |  
36. Karmarkar, A.B., I.D. Gonjari, A.H. Hosmani, P.N. Dhabale and S.B. Bhise, 2009. Dissolution rate enhancement of Fenofibrate using liquisolid tablet technique Part II: Evaluation of in vitro dissolution profile comparison methods. Latin Am. J. Pharm., 28: 538-543.
37. Hosmani, A.H., P.V. Kasture, I.D. Gonjari and A.B. Karmarkar, 2009. Study of formulation variables on properties of glipizide mucoadhesive microspheres by factorial design. DARU, 17: 236-244.
    Direct Link  |  
38. Gonjari, I.D., A.H. Hosmani, A.B. Karmarkar, A.S. Godage, S.B. Kadam and P.N. Dhabale, 2009. Formulation and evaluation of in situ gelling thermoreversible mucoadhesive gel of fluconazole. Drug Discoveries Ther., 3: 6-9.
    PubMed  |  Direct Link  |  
39. Gonjari, I.D., A.H. Hosmani, A.B. Karmarkar, A.B. Kadam, A.S. Godage and T.S. Khade, 2009. Microspheres of tramadol hydrochloride compressed along with loading dose: A modified approach for sustaining release. Drug Discoveries Ther., 3: 176-180.
    PubMed  |  Direct Link  |  
40. Gonjari, I.D., A.B. Karmarkar and P.V. Kasture, 2009. In vitro evaluation of different transnasal formulations of sumatriptan succinate: A comparative analysis. Drug Discoveries Therapeutics, 3: 266-271.
    PubMed  |  
41. Karmarkar, A.B., I.D. Gonjari, A.H. Hosmani, P.N. Dhabale and R.D. Thite, 2008. Preparation and in vitro evaluation of lyophilized nasal inserts of Tramadol Hydrochloride. Asian J. Pharm. Sci., 3: 276-283.
    Direct Link  |  
42. Karmarkar, A.B., I.D. Gonjari and A.H. Hosmani, 2008. Poloxamers and their applications. Online Int. Pharm. J., .
43. Gonjari, I.D., P.V. Kasture and A.B. Karmarkar, 2007. Solid in situ gelling nasal formulations: A tool for systemic drug delivery. Pharm. Rev., Vol. 5. .
44. Hosmani, A.H., A.B. Karmarkar and B.B. Karmarkar, 2006. Dissolution testing: Past, current and future perspectives. Curr. Pharm. Res. J., 1: 1-10.
    Direct Link  |